ApolloDx Awarded NIH Grant to Develop New Testing Device to Monitor Patient Compliance in Clinical Trials

Editor News

New technology has potential to save lives, save costs, produce more accurate data and perform clinical trials faster SALT LAKE CITY, UT—May 11, 2017—ApolloDx, a medical diagnostic company, today announced that it has been awarded a National Institute of Health (NIH) Phase 1 grant to develop an aptamer-based portable biosensor device to test for acetazolamide (ACZ) in patient urine. Results …

Entrepreneur Podcast Network: Apollo DX, providing laboratory-quality test results in 10 minutes or less

Editor News

Jared Bauer, MBA, the Co-founder and CEO of Apollo DX joins Enterprise Radio. Apollo DX’s Mobile Diagnostic Platform provides laboratory-quality test results in 10 minutes or less, expediting diagnosis and treatment for patients. Listen to interview with host Eric Dye & guest Jared Bauer discuss the following: What is Apollo Dx and what does the company do? How did you …

Multiplexing White Paper

Editor News

ApolloDx is pleased to announce that it has compiled a White Paper addressing the need for better Multiplexing in POC tests. Multiplexing enables the diagnostic testing device to lower healthcare costs by performing two or more tests per one consumable. Multiplexing becomes very powerful with the ApolloDx diagnostic technology particularly when testing more than one different analyte type such as, …

ApolloDx CEO Jared Bauer to be panelist at 19th Annual Bio Conference

Editor News

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because the mission is to support industry-wide success, Bio presents a broad and unbiased view of investment opportunities. Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, …

ApolloDx and CDx

Editor News

ApolloDx is pleased to announce that it has recently completed a White Paper addressing what ApolloDx can do for companion diagnostics. A summary is below: Pharma industry problems Dramatically decreasing efficiency in bringing new molecular entities (NME; new drugs) to market along with rapidly increasing pharmaceutical R&D spending. Many proprietary drug patent expire by 2015 totaling $150B in annual sales. …

Biochemist: Andrew Rasmussen

Editor News

ApolloDx is pleased to announce the addition of Andrew Joseph Rasmussen to to the team. Andrew graduated with his MS in Biochemistry from Utah State University. While at the University he performed cell cultures, protein purifications, kinetic characterizations and enzymatic studies on the enzyme nitrogenase. Andrew will be working with ApolloDx to develop additional infectious disease tests.

ApolloDx to present at BioTech Showcase

Editor News

ApolloDx will be presenting its revolutionary diagnostic technology at the 2016 BioTech Showcase in San Francisco on January 10th at 8:30 AM. The Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the …

ApolloDx to adopt FHIR

Editor News

ApolloDx is pleased to announce the decision to adopt the Fast Healthcare Interoperability Resources (FHIR, pronounced “fire”) standard. FHIR is a standard describing data formats and elements and an Application Programming Interface (API) for exchanging Electronic health records. The standard was created by the Health Level Seven International (HL7) health-care standards organization. FHIR builds on previous data format standards from HL7, like …

ApolloDx Android App Beta 2.0

Editor News

ApolloDx is pleased to announce the completion of the companies Android compatible app.  The ApolloDx app allows for bi-directional Bluetooth wireless communication with the latest iteration of the ApolloDx hardware.  The app can analyze the data from all of the currently developed ApolloDx tests.  In addition the app is connected to the companies secure HIPA compliant servers to allow for …

New Hardware Device

Editor News

ApolloDx is excited to announce the development of its third hardware prototype. Designed to beat current industry standards as well as to be used in a mobile environment ApolloDx’s device has exceeded even the companies highest expectations.  Validations of the device will be ongoing over the next few months.